Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-03-13A Randomized Trial of a Formal Group Program for Fatigue in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2017-03-03Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2017-03-03The Effects of Meditation on Pain, Fatigue and Physical Functioning in Patients With Multiple Sclerosis and Peripheral Neuropathy
-
CLINICAL_TRIALS study record update · 2017-02-24Assessment of Spasticity in MS Patients Using a Lido Workset
-
CLINICAL_TRIALS study record update · 2017-02-23Applications of Nanotechnology and Chemical Sensors for the Detection and Identification of Multiple Sclerosis by Respiratory Samples
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-02-23Improving Functional Performance in Persons With MS Via Physical Activity DVD Intervention
-
CLINICAL_TRIALS study record update · 2017-02-08A [C-11]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT-555 on Central Nervous System Inflammation in Subjects With Relapsing Forms of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2017-02-06An Open-Label, Randomized, Single Cross-over Study of Warm Compress Versus Usual Injection Site Preparation on Local Injection Site Reactions Among Persons With MS Who Perform Daily Injections of Copaxone®.
-
CLINICAL_TRIALS study record update · 2017-02-01Assessment of Ocrelizumab (OCR) Treatment Effects on Functional Impairment of MS Patients Enrolled in the Phase III Orchestra Programme Using Multimodal Evoked Potentials (EP) and Highresolution Electroencephalography (EEG)
-
CLINICAL_TRIALS study record update · 2017-02-01Multicenter Validation of The Evergreen Myometric Strength Test for Lower Extremities (EMST-LE) in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics
-
CLINICAL_TRIALS study record update · 2017-01-30Long-term Extension of the Multinational, Double-blind, Placebo Controlled Study EFC6049 (HMR1726D/3001) to Document the Safety of Two Doses of Teriflunomide (7 and 14 mg) in Patients With Multiple Sclerosis With Relapses
-
CLINICAL_TRIALS study record update · 2017-01-27Tolerability and Quality of Life in Patients With Multiple Sclerosis Switched to Intramuscular Interferon Beta 1a Autoinjector (Avonex® PenTM)
-
CLINICAL_TRIALS study record update · 2017-01-26Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2017-01-25Regulation of the Stress-axis by Vitamin D3 in Subjects With Multiple Sclerosis; a Double-blinded, Randomized, Placebo-controlled Study
-
CLINICAL_TRIALS study record update · 2017-01-23RESOunD: REbif Satisfaction On Discontinuing Oral Dimethyl Fumarate. A 24-week, Prospective, Open-label, Multicenter Trial Evaluating Treatment Satisfaction in Subjects With Relapsing Forms of Multiple Sclerosis Following Treatment Change From Tecfidera™ to Rebif® 44 mcg Subcutaneously (sc) Three Times Weekly (Tiw)
-
CLINICAL_TRIALS study record update · 2017-01-18Respiratory Function and Walking Capacity in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2017-01-16A Phase 1b, Double-blinded, Placebo-controlled, Randomized Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Ascending Doses Of Pf-06342674 (rn168) In Subjects With Multiple Sclerosis (ms)
-
CLINICAL_TRIALS study record update · 2017-01-10A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2017-01-09A Multicenter, Randomized, Double-Blind, Placebo-Controlled Exploratory Study to Assess the Effect of Treatment With Prolonged-Release Fampridine (BIIB041) 10 mg Twice Daily on Walking Ability and Balance in Subjects With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2017-01-09A Randomized, Blinded, Placebo-Controlled, Serial-Cohort, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2016-12-29ClinicalTrials.gov study NCT03004794
-
CLINICAL_TRIALS study record update · 2016-12-23ClinicalTrials.gov study NCT03001284
-
CLINICAL_TRIALS study record update · 2016-12-14Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/)
-
CLINICAL_TRIALS study record update · 2016-12-08A Randomized, Blinded, Parallel-Group, Phase 1 Study of Pharmacokinetics, Safety and Tolerability of Single Intravenous Doses of BIIB033 (Opicinumab ) Produced by 2 Manufacturing Processes, in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2016-12-08Self-Management Program Based on Physical Exercises for People With Multiple Sclerosis With Mild Neurological Impairment: A Randomized Controlled Trial